Agência regulatória norte-americana contraindica o uso de lidocaína para aliviar dor associada à dentição em lactentes e crianças.

Cebrim CFF

Palavras-chave


lidocaína, dentição, efeitos adversos, segurança do paciente.

Texto completo:

PDF

Referências


American Academy of Pediatrics. Teething: 4 to 7 Months. Available at: http://www.healthychildren.org/English/ages-stages/baby/teething-toothcare/pages/Teething-4-to-7-Months.aspx. Accessed on January 14, 2014.

Garrettson L, McGee E. Rapid onset of seizures following aspiration of viscous lidocaine. J Toxicol Clin Toxicol 1992;30:413-22.

Rothstein P, Dornbusch J, Shaywitz B. Prolonged seizures associated with the use of viscous lidocaine. J Pediatr 1982;101:461-3.

Giard MJ, Uden DL, Whitlock DJ. Seizures induced by oral viscous lidocaine. Clin Pharm 1983;2:110.

Puczynski MS, Ow EP, Rust C. Cardiopulmonary arrest due to misuse of viscous lidocaine. Arch Otolaryngol 1985;111:768-9.

Saikai RI, Lattin JE. Lidocaine ingestion. Am J Dis Child 1980;134:323.

Mofensen H, Caraccio T. Lidocaine toxicity from topical mucosal application. Clin Pediatr (Phila) 1983;22:190-2.

Texto traduzido e adaptado de: “U.S. Food and Drug Administration. Safety Announcement: FDA recommends not using lidocaine to treat teething pain and requires new Boxed Warning. [citado em 11 Dez 2014]. Disponível em: http://www.fda.gov/downloads/Drugs/DrugSafety/UCM402241.pdf


Apontamentos

  • Não há apontamentos.